March 28, 2014
Global pharmaceutical company Hospira Inc. agreed to pay $60 million on Thursday to settle a class action lawsuit accusing it of violating securities laws by providing misleading positive statements that artificially inflated share prices despite problems at the company's manufacturing plant.